date,datetime,title,summary,url,source,search_query,raw_content,finbert_sentiment,finbert_label,finbert_confidence,distilbert_sentiment,distilbert_label,distilbert_confidence,vader_compound,vader_positive,vader_negative,vader_neutral,textblob_polarity,textblob_subjectivity,ensemble_sentiment,confidence,fda_milestone_type,milestone_confidence,milestone_keywords_found,drug_specific,company_specific,importance_score,semantic_score
2020-06-11,2020-06-11 07:00:00,Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection) - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMi0AFBVV95cUxPZWtPRnhZNm1pemVzTi1Kd1pDV2ZqRkdCcTFtaTBGWkhHcWtsVk4wdUZ3RUEwNDJjNFFCWnhZSzdMOUl2NjJPZE12eEZjNzd6eVQxZDk1UHVkZkpTLXRLX0RJeFF0VDJvZFB5WFVjNFRheE1ncjhJb1pWYXhUXzFzaTFaZ3B0eldwajhVUk5abVdJaklYMGRHTUItUU5HcHJYdE9HV3Z6b1J0UkJRMzdHd2t2U1lHMXpzWkhkdVpzM0FTQkF0UVJfaGEzOEppUERi?oc=5"" target=""_blank"">Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection)</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMi0AFBVV95cUxPZWtPRnhZNm1pemVzTi1Kd1pDV2ZqRkdCcTFtaTBGWkhHcWtsVk4wdUZ3RUEwNDJjNFFCWnhZSzdMOUl2NjJPZE12eEZjNzd6eVQxZDk1UHVkZkpTLXRLX0RJeFF0VDJvZFB5WFVjNFRheE1ncjhJb1pWYXhUXzFzaTFaZ3B0eldwajhVUk5abVdJaklYMGRHTUItUU5HcHJYdE9HV3Z6b1J0UkJRMzdHd2t2U1lHMXpzWkhkdVpzM0FTQkF0UVJfaGEzOEppUERi?oc=5,Google News,Biocon Semglee FDA approval,"Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection) - PR Newswire <a href=""https://news.google.com/rss/articles/CBMi0AFBVV95cUxPZWtPRnhZNm1pemVzTi1Kd1pDV2ZqRkdCcTFtaTBGWkhHcWtsVk4wdUZ3RUEwNDJjNFFCWnhZSzdMOUl2NjJPZE12eEZjNzd6eVQxZDk1UHVkZkpTLXRLX0RJeFF0VDJvZFB5WFVjNFRheE1ncjhJb1pWYXhUXzFzaTFaZ3B0eldwajhVUk5abVdJaklYMGRHTUItUU5HcHJYdE9HV3Z6b1J0UkJRMzdHd2t2U1lHMXpzWkhkdVpzM0FTQkF0UVJfaGEzOEppUERi?oc=5"" target=""_blank"">Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection)</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",0.0,neutral,0.595608115196228,0.0,neutral,0.0,0.7351,0.181,0.0,0.819,0.0,0.0,0.0,0.6653540575981141,approval_process,0.5,['FDA approval'],True,True,26,0.0
2021-07-29,2021-07-29 07:00:00,Biocon Biologics interchangeable insulin Semglee gets US FDA approval - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics interchangeable insulin Semglee gets US FDA approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News,Biocon Semglee FDA approval,"Biocon Biologics interchangeable insulin Semglee gets US FDA approval - The Economic Times <a href=""https://news.google.com/rss/articles/CBMi9gFBVV95cUxNcEFTdFZtZlNDd2ZYdFlzQ2lXcXd4ZlBjcGVYdUE4Rm9Sa0UweXRXakIwcTJsbll0UWVpNDdxbzhBVU11TE9JdzBnd1g4ZkRScVdqSHNXQ0ZkSWFpYWFjdUpMenRhNXBleThCejd6ZnlLbFFQRHBLeGcxTnhQV3EwUnM4cG9vTk5ERWRFb3J2bkU4MGptVEpLREROeWQ0NXJHdG9QdFdLaGxmYXpvLTdDbGtWS1BJdUhGOFhOV0tWMTY2YzQ1RGxRRndRYTRhQ1k4S09hWFc4M1hvUFNtVm1JT0dCc0d4NFk4dm55TVRPMF9BVDVGQnfSAfsBQVVfeXFMTWx6NnAtal9OcTBCS2Z4QVBXNTNVMkFxdGxJOGhTX29Cejg0cDR2dk5UamZYN3JCWlh1WG9KOWZSaXN6enppRU91eEp1dlluNzhHSmJKY01qa1VQcEhvYnp2VzVseTh3QTNKTVRWU1Z1UlNlNk94UWdkRnlaam5CbDJSb19wSXhwMEF4Sm9VQTJ0TnViZGlzMXVNMGFpdFdITUhSRjVtVnFrZmV3WlhPRHc3c3hXMmI0VEhMckdoZjlIcnhfVVNHMDh6TWZCd0hOdEY2eHVWOXhmbDdXYzVnV3dxdlg1VjZMTlRCNU5YV3pxaGsyOEJJZGhuVkE?oc=5"" target=""_blank"">Biocon Biologics interchangeable insulin Semglee gets US FDA approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.0,neutral,0.7746681571006775,0.0,neutral,0.0,0.4767,0.11,0.0,0.89,0.13333333333333333,0.13333333333333333,0.0,0.46156716347800364,approval_process,0.5,['FDA approval'],True,True,26,0.0
2021-08-02,2021-08-02 07:00:00,Average Net Price for Insulin Glargine Declined After Basaglar Won FDA Approval - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNM2JWNFdSUFp3SlpDclRKNF9sejJqRlFTaW11eGpZSy1oYlRqMWphSjJyQnJ4dFlfRko0RFZMWFVKTjJja2pBaDl4emVPazczQmRSTDBuUms3X2w4emdXMXdUM2p1SlVpVHFCSmM0VGFkYmtsNnhFWHlCSDlObG5ZcUNha1lYX2ZXc0Q2SHlsN0JfNVBHd3BKZlpsT192X0JaT01Xa3ZjYS1aWWNBOXFTOV9iNVRDemgzQ1QwcHRB?oc=5"" target=""_blank"">Average Net Price for Insulin Glargine Declined After Basaglar Won FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxNM2JWNFdSUFp3SlpDclRKNF9sejJqRlFTaW11eGpZSy1oYlRqMWphSjJyQnJ4dFlfRko0RFZMWFVKTjJja2pBaDl4emVPazczQmRSTDBuUms3X2w4emdXMXdUM2p1SlVpVHFCSmM0VGFkYmtsNnhFWHlCSDlObG5ZcUNha1lYX2ZXc0Q2SHlsN0JfNVBHd3BKZlpsT192X0JaT01Xa3ZjYS1aWWNBOXFTOV9iNVRDemgzQ1QwcHRB?oc=5,Google News,Biocon Semglee FDA approval,"Average Net Price for Insulin Glargine Declined After Basaglar Won FDA Approval - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNM2JWNFdSUFp3SlpDclRKNF9sejJqRlFTaW11eGpZSy1oYlRqMWphSjJyQnJ4dFlfRko0RFZMWFVKTjJja2pBaDl4emVPazczQmRSTDBuUms3X2w4emdXMXdUM2p1SlVpVHFCSmM0VGFkYmtsNnhFWHlCSDlObG5ZcUNha1lYX2ZXc0Q2SHlsN0JfNVBHd3BKZlpsT192X0JaT01Xa3ZjYS1aWWNBOXFTOV9iNVRDemgzQ1QwcHRB?oc=5"" target=""_blank"">Average Net Price for Insulin Glargine Declined After Basaglar Won FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",-0.9178489446640015,negative,0.9178489446640015,0.0,neutral,0.0,0.8885,0.266,0.0,0.734,-0.05,0.1,-0.5244851112365723,0.6187829815546672,approval_process,0.5,['FDA approval'],False,False,11,0.0
2020-06-12,2020-06-12 07:00:00,"Biocon and Mylan receive US FDA approval for Semglee, an insulin glargine injection - Express Pharma","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon and Mylan receive US FDA approval for Semglee, an insulin glargine injection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.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?oc=5,Google News,Biocon Semglee FDA approval,"Biocon and Mylan receive US FDA approval for Semglee, an insulin glargine injection - Express Pharma <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon and Mylan receive US FDA approval for Semglee, an insulin glargine injection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",0.70448237657547,positive,0.70448237657547,0.0,neutral,0.0,0.7351,0.171,0.0,0.829,0.0,0.0,0.40256135804312565,0.719791188287735,approval_process,0.5,['FDA approval'],True,True,26,0.0
2018-12-31,2018-12-31 01:41:28,Table 3 . Biosimilar Insulins in Clinical Trials. - researchgate.net,"<a href=""https://news.google.com/rss/articles/CBMikwFBVV95cUxPMXhmOV9lakV1c2hyYl9oTjB6cXRlaG1pQ1pMSGh0X0J1Zkh5VFFQeVZXX0ZQTDF6bWFpdnpYVE5SWTR4VDZNVzloMm9qMElrQzBXYkhKWWxsVzdUN2hPWFU5V2gzOXdLYTVla2NSQTlYY1J3cUNyLW1fbW5wZC1qUjJRM2pqX1V0VmdhMWZhcnBUM0E?oc=5"" target=""_blank"">Table 3 . Biosimilar Insulins in Clinical Trials.</a>&nbsp;&nbsp;<font color=""#6f6f6f"">researchgate.net</font>",https://news.google.com/rss/articles/CBMikwFBVV95cUxPMXhmOV9lakV1c2hyYl9oTjB6cXRlaG1pQ1pMSGh0X0J1Zkh5VFFQeVZXX0ZQTDF6bWFpdnpYVE5SWTR4VDZNVzloMm9qMElrQzBXYkhKWWxsVzdUN2hPWFU5V2gzOXdLYTVla2NSQTlYY1J3cUNyLW1fbW5wZC1qUjJRM2pqX1V0VmdhMWZhcnBUM0E?oc=5,Google News,Biocon Semglee clinical trial,"Table 3 . Biosimilar Insulins in Clinical Trials. - researchgate.net <a href=""https://news.google.com/rss/articles/CBMikwFBVV95cUxPMXhmOV9lakV1c2hyYl9oTjB6cXRlaG1pQ1pMSGh0X0J1Zkh5VFFQeVZXX0ZQTDF6bWFpdnpYVE5SWTR4VDZNVzloMm9qMElrQzBXYkhKWWxsVzdUN2hPWFU5V2gzOXdLYTVla2NSQTlYY1J3cUNyLW1fbW5wZC1qUjJRM2pqX1V0VmdhMWZhcnBUM0E?oc=5"" target=""_blank"">Table 3 . Biosimilar Insulins in Clinical Trials.</a>&nbsp;&nbsp;<font color=""#6f6f6f"">researchgate.net</font>",0.0,neutral,0.9394456744194031,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9394456744194031,clinical_trials,0.35,['clinical trial'],True,False,18,0.0
2019-12-03,2019-12-03 08:00:00,Biocon gets FDA approval to produce pegfilgrastim in India - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxPVlFlbHpoSGZRU2RObzdFU1NSTnRYdzNIUkQwbU9sX09HSUZ6VVNzbkh0LVRCOFBXMGFvaFV2YVFKS091V3padVZOb0FiVDF5RGtqR1ZRUTJwdndqazFTQ1JqZC1jRHFUd2dZa21jbzE5UFFLRlBWNUx6UkxSN3dhUEdNdDBGWVNpbTV4WVhRajFTNUhvR1FjMV9qMk5JbEpidkZYRnI2Z1pWVjZOS2U4QW9JXzg?oc=5"" target=""_blank"">Biocon gets FDA approval to produce pegfilgrastim in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMitAFBVV95cUxPVlFlbHpoSGZRU2RObzdFU1NSTnRYdzNIUkQwbU9sX09HSUZ6VVNzbkh0LVRCOFBXMGFvaFV2YVFKS091V3padVZOb0FiVDF5RGtqR1ZRUTJwdndqazFTQ1JqZC1jRHFUd2dZa21jbzE5UFFLRlBWNUx6UkxSN3dhUEdNdDBGWVNpbTV4WVhRajFTNUhvR1FjMV9qMk5JbEpidkZYRnI2Z1pWVjZOS2U4QW9JXzg?oc=5,Google News,Biocon insulin biosimilar FDA,"Biocon gets FDA approval to produce pegfilgrastim in India - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxPVlFlbHpoSGZRU2RObzdFU1NSTnRYdzNIUkQwbU9sX09HSUZ6VVNzbkh0LVRCOFBXMGFvaFV2YVFKS091V3padVZOb0FiVDF5RGtqR1ZRUTJwdndqazFTQ1JqZC1jRHFUd2dZa21jbzE5UFFLRlBWNUx6UkxSN3dhUEdNdDBGWVNpbTV4WVhRajFTNUhvR1FjMV9qMk5JbEpidkZYRnI2Z1pWVjZOS2U4QW9JXzg?oc=5"" target=""_blank"">Biocon gets FDA approval to produce pegfilgrastim in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",0.8464288711547852,positive,0.8464288711547852,0.0,neutral,0.0,0.7351,0.22,0.0,0.78,0.0,0.0,0.48367364065987717,0.7907644355773926,approval_process,0.5,['FDA approval'],False,True,16,0.0
2021-07-29,2021-07-29 07:00:00,Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin - Beyond Type 1,"<a href=""https://news.google.com/rss/articles/CBMibkFVX3lxTE9lUDVIWEFPd0ZxQ214RDM4VU8wY3U5NmFrU0QzWXI3X3NIdllFZEtVRVd5N214ZmI3bnRkeHM5QS0taU85M21YSENrQnFRR1NCMDhKWmUxdXBJTTRfZ3l5Slh1VUFJNUlNUjY0aTRR?oc=5"" target=""_blank"">Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Beyond Type 1</font>",https://news.google.com/rss/articles/CBMibkFVX3lxTE9lUDVIWEFPd0ZxQ214RDM4VU8wY3U5NmFrU0QzWXI3X3NIdllFZEtVRVd5N214ZmI3bnRkeHM5QS0taU85M21YSENrQnFRR1NCMDhKWmUxdXBJTTRfZ3l5Slh1VUFJNUlNUjY0aTRR?oc=5,Google News,Semglee FDA approval 2021,"Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin - Beyond Type 1 <a href=""https://news.google.com/rss/articles/CBMibkFVX3lxTE9lUDVIWEFPd0ZxQ214RDM4VU8wY3U5NmFrU0QzWXI3X3NIdllFZEtVRVd5N214ZmI3bnRkeHM5QS0taU85M21YSENrQnFRR1NCMDhKWmUxdXBJTTRfZ3l5Slh1VUFJNUlNUjY0aTRR?oc=5"" target=""_blank"">Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Beyond Type 1</font>",0.8389886021614075,positive,0.8389886021614075,0.0,neutral,0.0,0.7351,0.212,0.0,0.788,0.16666666666666666,0.2222222222222222,0.4794220583779471,0.5802517562760248,approval_process,0.5,['FDA approval'],True,False,21,0.0
2021-08-03,2021-08-03 07:00:00,"Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval - Diabetes In Control","<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxQTmlfcWFyQTh5WEJpWEJueHFGeEdNN1YtV0hTTldVN3VRcGZvY24tems3TjRvNHFBakZTNFduWWtGUTc3eER6SklScFV0dmpoZTB5U0JXZlR6aEFBN0Zmbi04dkYzSlZkcEpoWE90WkNtNzNNVXNTTFdsM3ZXU0JVMmtxSFNXYmc3VnIwbVV5Z1lyVFVrX3pnRnEwbEdHdw?oc=5"" target=""_blank"">Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Diabetes In Control</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxQTmlfcWFyQTh5WEJpWEJueHFGeEdNN1YtV0hTTldVN3VRcGZvY24tems3TjRvNHFBakZTNFduWWtGUTc3eER6SklScFV0dmpoZTB5U0JXZlR6aEFBN0Zmbi04dkYzSlZkcEpoWE90WkNtNzNNVXNTTFdsM3ZXU0JVMmtxSFNXYmc3VnIwbVV5Z1lyVFVrX3pnRnEwbEdHdw?oc=5,Google News,Semglee FDA approval 2021,"Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval - Diabetes In Control <a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxQTmlfcWFyQTh5WEJpWEJueHFGeEdNN1YtV0hTTldVN3VRcGZvY24tems3TjRvNHFBakZTNFduWWtGUTc3eER6SklScFV0dmpoZTB5U0JXZlR6aEFBN0Zmbi04dkYzSlZkcEpoWE90WkNtNzNNVXNTTFdsM3ZXU0JVMmtxSFNXYmc3VnIwbVV5Z1lyVFVrX3pnRnEwbEdHdw?oc=5"" target=""_blank"">Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Diabetes In Control</font>",0.6942455172538757,positive,0.6942455172538757,0.0,neutral,0.0,0.4767,0.119,0.0,0.881,0.0,0.0,0.3967117241450718,0.5854727586269379,approval_process,0.5,['FDA approval'],True,False,21,0.0
2021-08-04,2021-08-04 07:00:00,"FDA Approvals Roundup: Semglee, Saphnelo, Uptravi - Regulatory Affairs Professionals Society | RAPS","<a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxQb3JBVkpMS3Q4TlIydHdYNGpPa29CelpOejFSVXFwQ0hobzdNOGdYTlc4c2ZPbXpFTDZxYU1lbGl6SzBvOTZZUFRTMnRzbHJxbDB4S0xVYWdrOGhSdE9oTGFpYUlOSFo4bkdrUjdSem0wVVBkUVNadUNLX3dGTU53bi1QQWtvS1M2LU5GU2tHbE9odG1XZ3cxNWU5cW55cUtVVnpNTUZJOEJzZw?oc=5"" target=""_blank"">FDA Approvals Roundup: Semglee, Saphnelo, Uptravi</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Regulatory Affairs Professionals Society | RAPS</font>",https://news.google.com/rss/articles/CBMiqgFBVV95cUxQb3JBVkpMS3Q4TlIydHdYNGpPa29CelpOejFSVXFwQ0hobzdNOGdYTlc4c2ZPbXpFTDZxYU1lbGl6SzBvOTZZUFRTMnRzbHJxbDB4S0xVYWdrOGhSdE9oTGFpYUlOSFo4bkdrUjdSem0wVVBkUVNadUNLX3dGTU53bi1QQWtvS1M2LU5GU2tHbE9odG1XZ3cxNWU5cW55cUtVVnpNTUZJOEJzZw?oc=5,Google News,Semglee FDA approval 2021,"FDA Approvals Roundup: Semglee, Saphnelo, Uptravi - Regulatory Affairs Professionals Society | RAPS <a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxQb3JBVkpMS3Q4TlIydHdYNGpPa29CelpOejFSVXFwQ0hobzdNOGdYTlc4c2ZPbXpFTDZxYU1lbGl6SzBvOTZZUFRTMnRzbHJxbDB4S0xVYWdrOGhSdE9oTGFpYUlOSFo4bkdrUjdSem0wVVBkUVNadUNLX3dGTU53bi1QQWtvS1M2LU5GU2tHbE9odG1XZ3cxNWU5cW55cUtVVnpNTUZJOEJzZw?oc=5"" target=""_blank"">FDA Approvals Roundup: Semglee, Saphnelo, Uptravi</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Regulatory Affairs Professionals Society | RAPS</font>",0.0,neutral,0.9213662147521973,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9213662147521973,approval_process,0.5,['FDA approval'],True,False,21,0.0
2017-09-18,2017-09-18 07:00:00,"Biocon's Vizag API plant clears US FDA inspection, shares up - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon's Vizag API plant clears US FDA inspection, shares up</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"Biocon's Vizag API plant clears US FDA inspection, shares up - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon's Vizag API plant clears US FDA inspection, shares up</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.773132860660553,positive,0.773132860660553,0.0,neutral,0.0,0.6124,0.259,0.0,0.741,0.0,0.0,0.4417902060917446,0.6927664303302765,regulatory_review,0.45,['FDA inspection'],False,True,15,0.0
2025-04-10,2025-04-10 07:00:00,"Biocon Biologics secures US FDA approval for Biosimilar Bevacizumab, JOBEVNE - Express Pharma","<a href=""https://news.google.com/rss/articles/CBMiqAFBVV95cUxOczFIemVhMFg4bFNuUVZVb2pFb1FpZ1U2N0xzOE90bXhhOWdIYzFpZDNhUWVrZ2p2QU9WdUJ2czRxTjhpTFJDUGcxWmtRS3pTdVgzbzNWSzE0azc0OW9EejUwRWtFWURMTjU0elhKek1iX1hCX3ZzVHotd0pUV2FXckh4TGpTY2MwamxsMTRFYzdWaGwwMzc3WFdPXy1oVjJxSW9FNHAzSkvSAa4BQVVfeXFMUEhYYklLRFBhRW9sMmNrdDhQVnJkc0Jnc01SQ0VfRWMtR01aZENKOUJ0UkZyXzJOcEo4MkswVHZsdEQzMmljTlZJQkVSVFkwMWtvVm5vUmpTMUdrUFR3a21SVEZBZU9GdTVQcGZMZFJIU0NuSEREdVItc0NlM3lNU2NWY2s2MTdJYW9lUlB3LWJCY1ZRLVg0bk9feUdCMkhUdmcxVmQ0Q0licGM3UTJn?oc=5"" target=""_blank"">Biocon Biologics secures US FDA approval for Biosimilar Bevacizumab, JOBEVNE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.com/rss/articles/CBMiqAFBVV95cUxOczFIemVhMFg4bFNuUVZVb2pFb1FpZ1U2N0xzOE90bXhhOWdIYzFpZDNhUWVrZ2p2QU9WdUJ2czRxTjhpTFJDUGcxWmtRS3pTdVgzbzNWSzE0azc0OW9EejUwRWtFWURMTjU0elhKek1iX1hCX3ZzVHotd0pUV2FXckh4TGpTY2MwamxsMTRFYzdWaGwwMzc3WFdPXy1oVjJxSW9FNHAzSkvSAa4BQVVfeXFMUEhYYklLRFBhRW9sMmNrdDhQVnJkc0Jnc01SQ0VfRWMtR01aZENKOUJ0UkZyXzJOcEo4MkswVHZsdEQzMmljTlZJQkVSVFkwMWtvVm5vUmpTMUdrUFR3a21SVEZBZU9GdTVQcGZMZFJIU0NuSEREdVItc0NlM3lNU2NWY2s2MTdJYW9lUlB3LWJCY1ZRLVg0bk9feUdCMkhUdmcxVmQ0Q0licGM3UTJn?oc=5,Google News,Biocon insulin biosimilar FDA,"Biocon Biologics secures US FDA approval for Biosimilar Bevacizumab, JOBEVNE - Express Pharma <a href=""https://news.google.com/rss/articles/CBMiqAFBVV95cUxOczFIemVhMFg4bFNuUVZVb2pFb1FpZ1U2N0xzOE90bXhhOWdIYzFpZDNhUWVrZ2p2QU9WdUJ2czRxTjhpTFJDUGcxWmtRS3pTdVgzbzNWSzE0azc0OW9EejUwRWtFWURMTjU0elhKek1iX1hCX3ZzVHotd0pUV2FXckh4TGpTY2MwamxsMTRFYzdWaGwwMzc3WFdPXy1oVjJxSW9FNHAzSkvSAa4BQVVfeXFMUEhYYklLRFBhRW9sMmNrdDhQVnJkc0Jnc01SQ0VfRWMtR01aZENKOUJ0UkZyXzJOcEo4MkswVHZsdEQzMmljTlZJQkVSVFkwMWtvVm5vUmpTMUdrUFR3a21SVEZBZU9GdTVQcGZMZFJIU0NuSEREdVItc0NlM3lNU2NWY2s2MTdJYW9lUlB3LWJCY1ZRLVg0bk9feUdCMkhUdmcxVmQ0Q0licGM3UTJn?oc=5"" target=""_blank"">Biocon Biologics secures US FDA approval for Biosimilar Bevacizumab, JOBEVNE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",0.5463883280754089,positive,0.5463883280754089,0.0,neutral,0.0,0.8689,0.329,0.0,0.671,0.0,0.0,0.3122219017573765,0.7076441640377045,approval_process,0.5,['FDA approval'],False,True,16,0.0
2025-04-10,2025-04-10 07:00:00,"Biocon Biologics Announces U.S. FDA Approval for Jobevne™, Biosimilar Bevacizumab, Expanding Its Oncology Portfolio - PR Newswire","<a href=""https://news.google.com/rss/articles/CBMi-gFBVV95cUxQcG5TMThQVFo3VWx4b2R4aWtKYVFYLWV4REk5SFc1M01TdTJ1SzZiU1AyUlEzNVBNNzUxYVduVUFoeDFUMm5TRUoxWU1LXzl3bm90UkZuLUtuTm5IRXpranhkc0RDckRBbkIxREVRNmNlejRpdlVuaXFGeTAweTRzQktueE5SS3RVc3ItTG52UHhnVkZ3V1lpV2xIQ0otVEU5Vko4T1FSVlhTdElPRFdTdUttSGhxOXpIYUo4MEoxWWtaWXpvNDJ0clNhQnV6VC1sWjJPMHlIZVBrd1JjVGhOWDl0ZXBXYzNmSFJjdTdleWxHdVExUXVtX3Nn?oc=5"" target=""_blank"">Biocon Biologics Announces U.S. FDA Approval for Jobevne™, Biosimilar Bevacizumab, Expanding Its Oncology Portfolio</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMi-gFBVV95cUxQcG5TMThQVFo3VWx4b2R4aWtKYVFYLWV4REk5SFc1M01TdTJ1SzZiU1AyUlEzNVBNNzUxYVduVUFoeDFUMm5TRUoxWU1LXzl3bm90UkZuLUtuTm5IRXpranhkc0RDckRBbkIxREVRNmNlejRpdlVuaXFGeTAweTRzQktueE5SS3RVc3ItTG52UHhnVkZ3V1lpV2xIQ0otVEU5Vko4T1FSVlhTdElPRFdTdUttSGhxOXpIYUo4MEoxWWtaWXpvNDJ0clNhQnV6VC1sWjJPMHlIZVBrd1JjVGhOWDl0ZXBXYzNmSFJjdTdleWxHdVExUXVtX3Nn?oc=5,Google News,Biocon insulin biosimilar FDA,"Biocon Biologics Announces U.S. FDA Approval for Jobevne™, Biosimilar Bevacizumab, Expanding Its Oncology Portfolio - PR Newswire <a href=""https://news.google.com/rss/articles/CBMi-gFBVV95cUxQcG5TMThQVFo3VWx4b2R4aWtKYVFYLWV4REk5SFc1M01TdTJ1SzZiU1AyUlEzNVBNNzUxYVduVUFoeDFUMm5TRUoxWU1LXzl3bm90UkZuLUtuTm5IRXpranhkc0RDckRBbkIxREVRNmNlejRpdlVuaXFGeTAweTRzQktueE5SS3RVc3ItTG52UHhnVkZ3V1lpV2xIQ0otVEU5Vko4T1FSVlhTdElPRFdTdUttSGhxOXpIYUo4MEoxWWtaWXpvNDJ0clNhQnV6VC1sWjJPMHlIZVBrd1JjVGhOWDl0ZXBXYzNmSFJjdTdleWxHdVExUXVtX3Nn?oc=5"" target=""_blank"">Biocon Biologics Announces U.S. FDA Approval for Jobevne™, Biosimilar Bevacizumab, Expanding Its Oncology Portfolio</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",0.9183073043823242,positive,0.9183073043823242,0.0,neutral,0.0,0.7351,0.162,0.0,0.838,0.0,0.0,0.5247470310756138,0.8267036521911622,approval_process,0.5,['FDA approval'],False,True,16,0.0
2023-10-09,2023-10-09 07:00:00,FDA hits Biocon's insulin copycat with a CRL as plant awaits pre-approval inspection - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMitwFBVV95cUxPNmZTQWVscmJKUVNMTmtvei0wVWs3UjBIODNmZGd3ZWhwazdBQ19zdHAwaVFoNzdvWGpaeDloc2tqSzZVVFdJRms2WDg5TW1DTTlDTGZWMWM5WWhkaGRHUjd5alhtOFZsb1FWN0tZdTdBU3RNOC1ESUtIWWFfWml6eTJDWGg3QkZmQjdvSk1OeThSVy05MW9YNGtyLTRyTmFJM0kyWGZKR2tSUGVycDB0SmdOZEVWSGs?oc=5"" target=""_blank"">FDA hits Biocon's insulin copycat with a CRL as plant awaits pre-approval inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMitwFBVV95cUxPNmZTQWVscmJKUVNMTmtvei0wVWs3UjBIODNmZGd3ZWhwazdBQ19zdHAwaVFoNzdvWGpaeDloc2tqSzZVVFdJRms2WDg5TW1DTTlDTGZWMWM5WWhkaGRHUjd5alhtOFZsb1FWN0tZdTdBU3RNOC1ESUtIWWFfWml6eTJDWGg3QkZmQjdvSk1OeThSVy05MW9YNGtyLTRyTmFJM0kyWGZKR2tSUGVycDB0SmdOZEVWSGs?oc=5,Google News,Biocon insulin biosimilar FDA,"FDA hits Biocon's insulin copycat with a CRL as plant awaits pre-approval inspection - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMitwFBVV95cUxPNmZTQWVscmJKUVNMTmtvei0wVWs3UjBIODNmZGd3ZWhwazdBQ19zdHAwaVFoNzdvWGpaeDloc2tqSzZVVFdJRms2WDg5TW1DTTlDTGZWMWM5WWhkaGRHUjd5alhtOFZsb1FWN0tZdTdBU3RNOC1ESUtIWWFfWml6eTJDWGg3QkZmQjdvSk1OeThSVy05MW9YNGtyLTRyTmFJM0kyWGZKR2tSUGVycDB0SmdOZEVWSGs?oc=5"" target=""_blank"">FDA hits Biocon's insulin copycat with a CRL as plant awaits pre-approval inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",-0.7395175695419312,negative,0.7395175695419312,0.0,neutral,0.0,0.1531,0.085,0.0,0.915,0.0,0.0,-0.4225814683096749,0.4463087847709656,regulatory_review,0.45,['pre-approval inspection'],False,True,15,0.0
2022-07-06,2022-07-06 07:00:00,Viatris starts yet another insulin biosimilar recall over potential missing labels - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxOM3gxV3NwMUNuWFhnSmZlUXFvZHdib1d0MklwczV1UWdCSkdrRXZYOVpMdi1NblhuVVNoMFNOSzdrS1l6alFzc1JxN3J4d0FXN3BrNlJsaFJ5dE82aldzMURNWk54emhOaUFjODUyVkVhcGxEWHlQTEJHWWdUMnYySlVXc1NxaElOZ0YtMXlJZ0doVlhWOVhyMWlwbHBucklwTGIzdmtzYm5RbTE4UWVmQndZdWVmMndsalE?oc=5"" target=""_blank"">Viatris starts yet another insulin biosimilar recall over potential missing labels</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxOM3gxV3NwMUNuWFhnSmZlUXFvZHdib1d0MklwczV1UWdCSkdrRXZYOVpMdi1NblhuVVNoMFNOSzdrS1l6alFzc1JxN3J4d0FXN3BrNlJsaFJ5dE82aldzMURNWk54emhOaUFjODUyVkVhcGxEWHlQTEJHWWdUMnYySlVXc1NxaElOZ0YtMXlJZ0doVlhWOVhyMWlwbHBucklwTGIzdmtzYm5RbTE4UWVmQndZdWVmMndsalE?oc=5,Google News,Biocon insulin biosimilar FDA,"Viatris starts yet another insulin biosimilar recall over potential missing labels - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxOM3gxV3NwMUNuWFhnSmZlUXFvZHdib1d0MklwczV1UWdCSkdrRXZYOVpMdi1NblhuVVNoMFNOSzdrS1l6alFzc1JxN3J4d0FXN3BrNlJsaFJ5dE82aldzMURNWk54emhOaUFjODUyVkVhcGxEWHlQTEJHWWdUMnYySlVXc1NxaElOZ0YtMXlJZ0doVlhWOVhyMWlwbHBucklwTGIzdmtzYm5RbTE4UWVmQndZdWVmMndsalE?oc=5"" target=""_blank"">Viatris starts yet another insulin biosimilar recall over potential missing labels</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",-0.7730820775032043,negative,0.7730820775032043,0.0,neutral,0.0,-0.5267,0.0,0.145,0.855,-0.08,0.41999999999999993,-0.44176118714468815,0.4599273591677348,regulatory_issues,0.4,['recall'],False,False,9,0.0
2024-09-19,2024-09-19 07:00:00,Granules India scolded over truckloads of torn manufacturing documents after recent FDA inspection - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMivAFBVV95cUxQa0M4b3g4LThibmRENjZLbDVNZXczX2JMc1FLYzIwOWV1dmZ5RE5JUURQdGwzS005c29Vak1qbUhRMXRsV0xkTDFSaENMZGdfaVZUNDNTQ3ZnMXNZQTEycDMzbGVHdVRnbzlQZ3NxT3dGSmNiSjFvaVAwcXpseXRjNlB6QnhGcVIxRkdPT2NYLVR4V1FQSmEtSEJkT2czVXBKZURrcktkWE1VYU5JS3lXaDBzQnJ4dHBXclRwRQ?oc=5"" target=""_blank"">Granules India scolded over truckloads of torn manufacturing documents after recent FDA inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMivAFBVV95cUxQa0M4b3g4LThibmRENjZLbDVNZXczX2JMc1FLYzIwOWV1dmZ5RE5JUURQdGwzS005c29Vak1qbUhRMXRsV0xkTDFSaENMZGdfaVZUNDNTQ3ZnMXNZQTEycDMzbGVHdVRnbzlQZ3NxT3dGSmNiSjFvaVAwcXpseXRjNlB6QnhGcVIxRkdPT2NYLVR4V1FQSmEtSEJkT2czVXBKZURrcktkWE1VYU5JS3lXaDBzQnJ4dHBXclRwRQ?oc=5,Google News,Biocon FDA inspection,"Granules India scolded over truckloads of torn manufacturing documents after recent FDA inspection - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMivAFBVV95cUxQa0M4b3g4LThibmRENjZLbDVNZXczX2JMc1FLYzIwOWV1dmZ5RE5JUURQdGwzS005c29Vak1qbUhRMXRsV0xkTDFSaENMZGdfaVZUNDNTQ3ZnMXNZQTEycDMzbGVHdVRnbzlQZ3NxT3dGSmNiSjFvaVAwcXpseXRjNlB6QnhGcVIxRkdPT2NYLVR4V1FQSmEtSEJkT2czVXBKZURrcktkWE1VYU5JS3lXaDBzQnJ4dHBXclRwRQ?oc=5"" target=""_blank"">Granules India scolded over truckloads of torn manufacturing documents after recent FDA inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",-0.9660661220550537,negative,0.9660661220550537,0.0,neutral,0.0,-0.4588,0.0,0.118,0.882,0.0,0.16666666666666666,-0.5520377840314592,0.7124330610275269,regulatory_review,0.45,['FDA inspection'],False,False,10,0.0
2023-08-18,2023-08-18 07:00:00,Another FDA inspection ends in 483 for Biocon in Malaysia - BioProcess International,"<a href=""https://news.google.com/rss/articles/CBMiogFBVV95cUxNQkJLMk90M3R5dkYybGthQ0ZvcUNOMXRVdDNkYldCYTk4WUw1alpvYTVmRVlyYmRzei12cmx2cEVfTXlKY0ZPMlE5bkEwaFdsM0FacmRxaUFKc2lTRFVnamlWRVJvcnVTREFzTGhDaE8tdTB0UXFOeGxnejkxcF9rT25xZG1FWnhuMVJrN3lEdUhPY2RESTR5MnFiM0FiMjJ5RHc?oc=5"" target=""_blank"">Another FDA inspection ends in 483 for Biocon in Malaysia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioProcess International</font>",https://news.google.com/rss/articles/CBMiogFBVV95cUxNQkJLMk90M3R5dkYybGthQ0ZvcUNOMXRVdDNkYldCYTk4WUw1alpvYTVmRVlyYmRzei12cmx2cEVfTXlKY0ZPMlE5bkEwaFdsM0FacmRxaUFKc2lTRFVnamlWRVJvcnVTREFzTGhDaE8tdTB0UXFOeGxnejkxcF9rT25xZG1FWnhuMVJrN3lEdUhPY2RESTR5MnFiM0FiMjJ5RHc?oc=5,Google News,Biocon FDA inspection,"Another FDA inspection ends in 483 for Biocon in Malaysia - BioProcess International <a href=""https://news.google.com/rss/articles/CBMiogFBVV95cUxNQkJLMk90M3R5dkYybGthQ0ZvcUNOMXRVdDNkYldCYTk4WUw1alpvYTVmRVlyYmRzei12cmx2cEVfTXlKY0ZPMlE5bkEwaFdsM0FacmRxaUFKc2lTRFVnamlWRVJvcnVTREFzTGhDaE8tdTB0UXFOeGxnejkxcF9rT25xZG1FWnhuMVJrN3lEdUhPY2RESTR5MnFiM0FiMjJ5RHc?oc=5"" target=""_blank"">Another FDA inspection ends in 483 for Biocon in Malaysia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioProcess International</font>",0.0,neutral,0.8516349792480469,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8516349792480469,regulatory_review,0.45,['FDA inspection'],False,True,15,0.0
2024-08-05,2024-08-05 07:00:00,Biocon gets US FDA report after Vizag facility scan; no more regulatory action needed - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gets US FDA report after Vizag facility scan; no more regulatory action needed</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"Biocon gets US FDA report after Vizag facility scan; no more regulatory action needed - CNBC TV18 <a href=""https://news.google.com/rss/articles/CBMi2wFBVV95cUxQbXJ1amtyWDRXUmRXb0g2bWs1ZVNqRHV3RXVYQmliNkJ0aVplamxETWZHblEtQVRxZVZUcGJlN2c1S1lhWGhrVEtmMzNjRm1TR05oWVBYc0hmZ1V0M3VrX0g3TjJoMmt3RVNCREVqcU1kS25zY3BwSVZTNUd2UTRDZ1p4RnJzdkdLWXoyakdnM1dEYWxhWlhfaGxhUDc2UTZ5ZnJDNlFic0hvRWh3bmNOeHY2UldhOG81QTczemNGUklhN2xCV082NTRtc3hyelc0Qlpib1ZPUTBzVHPSAeABQVVfeXFMTnhFeDlmbFNWbHpWYnNqdHMySDA3TzRuNFk2dEZTcGg4Z0xaeDEycXVlQ0M0ZG1YMnd0NWV4Ti1va3czVGlOTzZpQ1dMaTFwR2pmSzVMRHpxdDZORzhsTVd2RERaTC1iaHNDQmk2M09jT0xoUkREUk1xUFkxOEhVUzNVT2ZSdVlfMy1KV3dTZjIwaUJrMjgyWGpQRkQtdG9IcHFjM3NHQUhfUWk3RF9BalhINFFIdVNhTEx1MkVqTGhuTFJsZjAzMjdKbHBmUkg2S2x4NkRUX3o5SUY0RHZMM2Q?oc=5"" target=""_blank"">Biocon gets US FDA report after Vizag facility scan; no more regulatory action needed</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.0,neutral,0.9117307662963867,0.0,neutral,0.0,-0.5267,0.0,0.121,0.879,-0.06000000000000001,0.24000000000000005,0.0,0.4994769220987956,regulatory_issues,0.4,['regulatory action'],False,True,14,0.0
2024-06-15,2024-06-15 07:00:00,Biocon API facility in Visakhapatnam receives 3 observations from USFDA inspection - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon API facility in Visakhapatnam receives 3 observations from USFDA inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"Biocon API facility in Visakhapatnam receives 3 observations from USFDA inspection - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon API facility in Visakhapatnam receives 3 observations from USFDA inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.6728252172470093,positive,0.6728252172470093,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.3844715527125767,0.6728252172470093,regulatory_review,0.45,['FDA inspection'],False,True,15,0.0
2023-10-18,2023-10-18 07:00:00,Biocon shares fall most in three months as Malaysia unit may face approval delays post USFDA inspection - CNBC TV18,"<a href=""https://news.google.com/rss/articles/CBMizAFBVV95cUxQdDdzTTJzM3JrVERWUGNWenRvMGFJX0xZaVJ4Y1gzZk82Tm02bTNqdFNWNDY1eTM3NXVYU01lMWxhMFcwTmxUOU1QVUdtejFPbS1tR19uTmhHVk1VTk1WY1RUbk1US21tcjIwb0Z4R0ZHRDJYODduRTZCUGcwbVRSRXNVazBGRF9oSDVhdnBBejFmdi02cm1QSnktT2dfOUwyWlFKdHlud19zWlI4WTBHSlY0ZFpjMEpOdTdyaGllazVBWGJOLUlIT0owZEbSAdIBQVVfeXFMTXhhX1dyT25JTWRUY2wwTWRIUFVGajBzbmh3amdpVUVMQ0dwYk5PTFRTSThsNHhYOWEzQmNiOUhRRzB0UURkRlNDcWNuY3VMa3ExMEdrQzhkN3NicGszcFQ4OUhLX2lVRGJmLTRrc0RkZ0tPeF9OTk5IdGx2Mi13NFRzUnRGUU1DenYydVJ1ckh6RFFKcHVMc19lZjhuRGtreFlIZkdBQ2sycTJVb244eGloMFlxSWgyOExhQ25jQ05lQW5MbkxyUndpYmZHRHJmMkxR?oc=5"" target=""_blank"">Biocon shares fall most in three months as Malaysia unit may face approval delays post USFDA inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"Biocon shares fall most in three months as Malaysia unit may face approval delays post USFDA inspection - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares fall most in three months as Malaysia unit may face approval delays post USFDA inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",-0.9671845436096191,negative,0.9671845436096191,0.0,neutral,0.0,0.8625,0.227,0.0,0.773,0.3333333333333333,0.3333333333333333,-0.5526768820626395,0.7210059589809842,regulatory_review,0.45,['FDA inspection'],False,True,15,0.0
2025-01-07,2025-01-07 08:00:00,"Biocon stock zooms over 8% on Psoriasis drug approval from Japan, Jefferies rating upgrade - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon stock zooms over 8% on Psoriasis drug approval from Japan, Jefferies rating upgrade</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News,Biocon regulatory approval,"Biocon stock zooms over 8% on Psoriasis drug approval from Japan, Jefferies rating upgrade - Mint <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon stock zooms over 8% on Psoriasis drug approval from Japan, Jefferies rating upgrade</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.8767358064651489,positive,0.8767358064651489,0.0,neutral,0.0,0.7351,0.171,0.0,0.829,0.0,0.0,0.5009918894086565,0.8059179032325745,approval_process,0.5,['drug approval'],False,True,16,0.0
2025-04-28,2025-04-28 07:00:00,"Zydus Lifesciences, Biocon, and Aurobindo Pharma Shares Rise on Fresh Regulatory Approvals - Equitypandit","<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxNU1ZBMkczS3B4SWZ5WGVoVzBWcmNqUHdkTU53MXdTSFVBaWdMMFZyUW42NE5NRjc4Z0NudGItQnNqdFVEc3lkZmpQVF96RFlnY0dpdlkzRkphRkZTUkNKd2xOSEJvdXpMaW9Wc3VmOGJLeEdndmpmQjFhakpfbTlvRWJiRDBiMTNwSE9rcVVRa1ZJREdXYkVyb3MydkYyNkU2RzJyN2NEN0hBNHNMUVRvejctem5uVUt6SkE?oc=5"" target=""_blank"">Zydus Lifesciences, Biocon, and Aurobindo Pharma Shares Rise on Fresh Regulatory Approvals</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxNU1ZBMkczS3B4SWZ5WGVoVzBWcmNqUHdkTU53MXdTSFVBaWdMMFZyUW42NE5NRjc4Z0NudGItQnNqdFVEc3lkZmpQVF96RFlnY0dpdlkzRkphRkZTUkNKd2xOSEJvdXpMaW9Wc3VmOGJLeEdndmpmQjFhakpfbTlvRWJiRDBiMTNwSE9rcVVRa1ZJREdXYkVyb3MydkYyNkU2RzJyN2NEN0hBNHNMUVRvejctem5uVUt6SkE?oc=5,Google News,Biocon regulatory approval,"Zydus Lifesciences, Biocon, and Aurobindo Pharma Shares Rise on Fresh Regulatory Approvals - Equitypandit <a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxNU1ZBMkczS3B4SWZ5WGVoVzBWcmNqUHdkTU53MXdTSFVBaWdMMFZyUW42NE5NRjc4Z0NudGItQnNqdFVEc3lkZmpQVF96RFlnY0dpdlkzRkphRkZTUkNKd2xOSEJvdXpMaW9Wc3VmOGJLeEdndmpmQjFhakpfbTlvRWJiRDBiMTNwSE9rcVVRa1ZJREdXYkVyb3MydkYyNkU2RzJyN2NEN0hBNHNMUVRvejctem5uVUt6SkE?oc=5"" target=""_blank"">Zydus Lifesciences, Biocon, and Aurobindo Pharma Shares Rise on Fresh Regulatory Approvals</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",0.9370501637458801,positive,0.9370501637458801,0.0,neutral,0.0,0.7906,0.273,0.0,0.727,0.19999999999999998,0.3333333333333333,0.5354572364262172,0.64255005458196,approval_process,0.5,['regulatory approval'],False,True,16,0.0
2025-04-11,2025-04-11 07:00:00,"Biocon Shares in Focus, Strengthens US Oncology Footprint with Biosimilar Approval - Groww","<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxOR195WnVUMnhKeVg3Sk16NmFQbkY3cDU1QlE1eEUzV1dmdmtmRkRuNFAwRWptdFJuNG4xdFJrYU5JWWZTSm9vTzZfZHhkdWhIcjhSU1FDOWVwa0JXWnBPMGNNenlkWEhYaW1zZ1d4c0VkUUJkaUwyc3FFZnBzVjZBMGtsLWRydGw5ZkhMbFdFTFJleHVKTnFCdlViZXcxdw?oc=5"" target=""_blank"">Biocon Shares in Focus, Strengthens US Oncology Footprint with Biosimilar Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Groww</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxOR195WnVUMnhKeVg3Sk16NmFQbkY3cDU1QlE1eEUzV1dmdmtmRkRuNFAwRWptdFJuNG4xdFJrYU5JWWZTSm9vTzZfZHhkdWhIcjhSU1FDOWVwa0JXWnBPMGNNenlkWEhYaW1zZ1d4c0VkUUJkaUwyc3FFZnBzVjZBMGtsLWRydGw5ZkhMbFdFTFJleHVKTnFCdlViZXcxdw?oc=5,Google News,Biocon regulatory approval,"Biocon Shares in Focus, Strengthens US Oncology Footprint with Biosimilar Approval - Groww <a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxOR195WnVUMnhKeVg3Sk16NmFQbkY3cDU1QlE1eEUzV1dmdmtmRkRuNFAwRWptdFJuNG4xdFJrYU5JWWZTSm9vTzZfZHhkdWhIcjhSU1FDOWVwa0JXWnBPMGNNenlkWEhYaW1zZ1d4c0VkUUJkaUwyc3FFZnBzVjZBMGtsLWRydGw5ZkhMbFdFTFJleHVKTnFCdlViZXcxdw?oc=5"" target=""_blank"">Biocon Shares in Focus, Strengthens US Oncology Footprint with Biosimilar Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Groww</font>",0.9288952946662903,positive,0.9288952946662903,0.0,neutral,0.0,0.91,0.391,0.0,0.609,0.0,0.0,0.5307973112378802,0.9194476473331452,approval_process,0.5,['biosimilar approval'],False,True,16,0.0
2025-04-11,2025-04-11 07:00:00,Biocon Share Price Rises 5.5% After USFDA Approval For JOBEVNE Biosimilar - Samco,"<a href=""https://news.google.com/rss/articles/CBMiwgFBVV95cUxOT2tPSFdjb2k4bFdmQ1ozeG95NkpOcG5DcGFxZDRUazJEVExuaUluYTkwc1NyLUlySHVIR2tWWUJEaUZfZV9jbS05Vk9HTUhJM1BQVUpkTVF4b253SlY1NWwyYU5XSHhSSDloZTZUNGJLSEhrbXMtOEduX25kTUV6ZE9QdFNSM3J5YjdRWjJuSEhqWDdDZDZWUGd4WWIxU0pTVU5jMXJQMTRfNDVGd2xIamRLdVdIT3FOT2VYMVNheERwdw?oc=5"" target=""_blank"">Biocon Share Price Rises 5.5% After USFDA Approval For JOBEVNE Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Samco</font>",https://news.google.com/rss/articles/CBMiwgFBVV95cUxOT2tPSFdjb2k4bFdmQ1ozeG95NkpOcG5DcGFxZDRUazJEVExuaUluYTkwc1NyLUlySHVIR2tWWUJEaUZfZV9jbS05Vk9HTUhJM1BQVUpkTVF4b253SlY1NWwyYU5XSHhSSDloZTZUNGJLSEhrbXMtOEduX25kTUV6ZE9QdFNSM3J5YjdRWjJuSEhqWDdDZDZWUGd4WWIxU0pTVU5jMXJQMTRfNDVGd2xIamRLdVdIT3FOT2VYMVNheERwdw?oc=5,Google News,Biocon regulatory approval,"Biocon Share Price Rises 5.5% After USFDA Approval For JOBEVNE Biosimilar - Samco <a href=""https://news.google.com/rss/articles/CBMiwgFBVV95cUxOT2tPSFdjb2k4bFdmQ1ozeG95NkpOcG5DcGFxZDRUazJEVExuaUluYTkwc1NyLUlySHVIR2tWWUJEaUZfZV9jbS05Vk9HTUhJM1BQVUpkTVF4b253SlY1NWwyYU5XSHhSSDloZTZUNGJLSEhrbXMtOEduX25kTUV6ZE9QdFNSM3J5YjdRWjJuSEhqWDdDZDZWUGd4WWIxU0pTVU5jMXJQMTRfNDVGd2xIamRLdVdIT3FOT2VYMVNheERwdw?oc=5"" target=""_blank"">Biocon Share Price Rises 5.5% After USFDA Approval For JOBEVNE Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Samco</font>",0.936037003993988,positive,0.936037003993988,0.0,neutral,0.0,0.8625,0.325,0.0,0.675,0.0,0.0,0.5348782879965646,0.899268501996994,approval_process,0.5,['FDA approval'],False,True,16,0.0
2025-01-07,2025-01-07 08:00:00,"Biocon shares gain 8% after Psoriasis drug approval from Japan, Jefferies upgrade - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares gain 8% after Psoriasis drug approval from Japan, Jefferies upgrade</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon regulatory approval,"Biocon shares gain 8% after Psoriasis drug approval from Japan, Jefferies upgrade - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares gain 8% after Psoriasis drug approval from Japan, Jefferies upgrade</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.8878949880599976,positive,0.8878949880599976,0.0,neutral,0.0,0.9468,0.42,0.0,0.58,0.0,0.0,0.5073685646057129,0.9173474940299988,approval_process,0.5,['drug approval'],False,True,16,0.0
2022-11-16,2022-11-16 08:00:00,Biocon Biologics secures regulatory approvals for acquisition of Viatris' biosimilar business - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics secures regulatory approvals for acquisition of Viatris' biosimilar business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News,Biocon regulatory approval,"Biocon Biologics secures regulatory approvals for acquisition of Viatris' biosimilar business - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics secures regulatory approvals for acquisition of Viatris' biosimilar business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.7135533094406128,positive,0.7135533094406128,0.0,neutral,0.0,0.5574,0.141,0.0,0.859,0.13333333333333333,0.13333333333333333,0.4077447482517787,0.46809554759131533,approval_process,0.5,['regulatory approval'],False,True,16,0.0
2025-04-28,2025-04-28 07:00:00,Pharma stocks jumps 3% after securing regulatory approvals from USFDA and EMA - Trade Brains,"<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxPMjNlVFpucURuR0NYN1RwalhfbEd6T3Y3M0NvX2NfdExPUGJPRGJjV0RxWjBVUjg5ZzBDUVFZanJtUHlsZ1YzQ1RrcFF0T2NDeFFHcUR2cF9zaUlrMDkyZTZ2YmhuMmR1dUtEd0xXNHNoUmtVSDdHbnk4aW1UQ2Y5SDJtakc3RjE4VUx1Rnd4cnpxcng3Rjk5RElfVy1tbU9kYWNZSWhKTjN0Mmpodmc?oc=5"" target=""_blank"">Pharma stocks jumps 3% after securing regulatory approvals from USFDA and EMA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Trade Brains</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxPMjNlVFpucURuR0NYN1RwalhfbEd6T3Y3M0NvX2NfdExPUGJPRGJjV0RxWjBVUjg5ZzBDUVFZanJtUHlsZ1YzQ1RrcFF0T2NDeFFHcUR2cF9zaUlrMDkyZTZ2YmhuMmR1dUtEd0xXNHNoUmtVSDdHbnk4aW1UQ2Y5SDJtakc3RjE4VUx1Rnd4cnpxcng3Rjk5RElfVy1tbU9kYWNZSWhKTjN0Mmpodmc?oc=5,Google News,Biocon regulatory approval,"Pharma stocks jumps 3% after securing regulatory approvals from USFDA and EMA - Trade Brains <a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxPMjNlVFpucURuR0NYN1RwalhfbEd6T3Y3M0NvX2NfdExPUGJPRGJjV0RxWjBVUjg5ZzBDUVFZanJtUHlsZ1YzQ1RrcFF0T2NDeFFHcUR2cF9zaUlrMDkyZTZ2YmhuMmR1dUtEd0xXNHNoUmtVSDdHbnk4aW1UQ2Y5SDJtakc3RjE4VUx1Rnd4cnpxcng3Rjk5RElfVy1tbU9kYWNZSWhKTjN0Mmpodmc?oc=5"" target=""_blank"">Pharma stocks jumps 3% after securing regulatory approvals from USFDA and EMA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Trade Brains</font>",0.931842029094696,positive,0.931842029094696,0.0,neutral,0.0,0.5574,0.141,0.0,0.859,0.0,0.0,0.5324811594826834,0.744621014547348,approval_process,0.5,['regulatory approval'],False,False,11,0.0
2024-12-02,2024-12-02 08:00:00,Biocon Shares Rally 4% as Subsidiary Receives USFDA Approval - Equitypandit,"<a href=""https://news.google.com/rss/articles/CBMikwFBVV95cUxNaFJkbmZMcXBWSTBXcktrelhhbnBDOEFjMkRmRzg4M0Z3VmZxRjFhekc4U21YRmlvNUtmSG5tRDN4OVVyVV9MZDdpNkJrSnZvV2ZaTDRsZ3JsR2s3VUFoRW5YWWRaMEdqWEdPckpRaGhkamF6UmRSNllKWWlub1BVVEFWaHVJMGlNNzZQWWotbS1tOGM?oc=5"" target=""_blank"">Biocon Shares Rally 4% as Subsidiary Receives USFDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",https://news.google.com/rss/articles/CBMikwFBVV95cUxNaFJkbmZMcXBWSTBXcktrelhhbnBDOEFjMkRmRzg4M0Z3VmZxRjFhekc4U21YRmlvNUtmSG5tRDN4OVVyVV9MZDdpNkJrSnZvV2ZaTDRsZ3JsR2s3VUFoRW5YWWRaMEdqWEdPckpRaGhkamF6UmRSNllKWWlub1BVVEFWaHVJMGlNNzZQWWotbS1tOGM?oc=5,Google News,Biocon regulatory approval,"Biocon Shares Rally 4% as Subsidiary Receives USFDA Approval - Equitypandit <a href=""https://news.google.com/rss/articles/CBMikwFBVV95cUxNaFJkbmZMcXBWSTBXcktrelhhbnBDOEFjMkRmRzg4M0Z3VmZxRjFhekc4U21YRmlvNUtmSG5tRDN4OVVyVV9MZDdpNkJrSnZvV2ZaTDRsZ3JsR2s3VUFoRW5YWWRaMEdqWEdPckpRaGhkamF6UmRSNllKWWlub1BVVEFWaHVJMGlNNzZQWWotbS1tOGM?oc=5"" target=""_blank"">Biocon Shares Rally 4% as Subsidiary Receives USFDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",0.9109441041946411,positive,0.9109441041946411,0.0,neutral,0.0,0.7579,0.283,0.0,0.717,0.0,0.0,0.5205394881112235,0.8344220520973206,approval_process,0.5,['FDA approval'],False,True,16,0.0
2025-01-07,2025-01-07 08:00:00,Biocon’s Share Price Soars Following Jefferies Upgrade and Regulatory Approval - theafricalogistics.com,"<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxOcEQzSWd0LU5iZmkyMjFqLVpodzdyWVBVc3JhbjhoMHNBRUViYlB3aS14YmRicF80VDU3d01QUGF1M0tPcnpXMGs2UWZONmljTHlKOW02MkhoYzc0WXlxR0huRmpiM1ZqdGtnMXFqN05hYTZEeXg1cWtKZ2pZRTZfai1WajlpUzBUX2NFcHNuNXdEMUdhaUFMRkR1bFhLTEoyOWU3b0RTWGMxXzVvU0E?oc=5"" target=""_blank"">Biocon’s Share Price Soars Following Jefferies Upgrade and Regulatory Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">theafricalogistics.com</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxOcEQzSWd0LU5iZmkyMjFqLVpodzdyWVBVc3JhbjhoMHNBRUViYlB3aS14YmRicF80VDU3d01QUGF1M0tPcnpXMGs2UWZONmljTHlKOW02MkhoYzc0WXlxR0huRmpiM1ZqdGtnMXFqN05hYTZEeXg1cWtKZ2pZRTZfai1WajlpUzBUX2NFcHNuNXdEMUdhaUFMRkR1bFhLTEoyOWU3b0RTWGMxXzVvU0E?oc=5,Google News,Biocon regulatory approval,"Biocon’s Share Price Soars Following Jefferies Upgrade and Regulatory Approval - theafricalogistics.com <a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxOcEQzSWd0LU5iZmkyMjFqLVpodzdyWVBVc3JhbjhoMHNBRUViYlB3aS14YmRicF80VDU3d01QUGF1M0tPcnpXMGs2UWZONmljTHlKOW02MkhoYzc0WXlxR0huRmpiM1ZqdGtnMXFqN05hYTZEeXg1cWtKZ2pZRTZfai1WajlpUzBUX2NFcHNuNXdEMUdhaUFMRkR1bFhLTEoyOWU3b0RTWGMxXzVvU0E?oc=5"" target=""_blank"">Biocon’s Share Price Soars Following Jefferies Upgrade and Regulatory Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">theafricalogistics.com</font>",0.835119903087616,positive,0.835119903087616,0.0,neutral,0.0,0.7579,0.263,0.0,0.737,0.0,0.06666666666666667,0.47721137319292345,0.796509951543808,approval_process,0.5,['regulatory approval'],False,True,16,0.0
2022-03-14,2022-03-14 07:00:00,Niramai receives FDA clearance for SMILE-100 System - ET HealthWorld,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Niramai receives FDA clearance for SMILE-100 System</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News,Kiran Mazumdar-Shaw FDA,"Niramai receives FDA clearance for SMILE-100 System - ET HealthWorld <a href=""https://news.google.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?oc=5"" target=""_blank"">Niramai receives FDA clearance for SMILE-100 System</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",0.7774776220321655,positive,0.7774776220321655,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.4442729268755231,0.7774776220321655,approval_process,0.5,['FDA clearance'],False,False,11,0.0
2024-05-21,2024-05-21 07:00:00,Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili™. Enters U.S. Ophthalmology Market - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMi-wFBVV95cUxOeGRuOEpEaURCa1IyQjZsSzkydERHN2VJYmdHSm1pZFRhMFN4SzdJcDZCVERQbHZJQVczVVJjQUFQNXNyZWpLLTBiVjhuMUhwWWZkVHVPNjlUUUh0X3RHQTAxdHE0WHdhdGVJWDZ5U0ZVMzZydjMxRmtWUng3OWFQSFpIUmw4ME1MYjNiNHEtOEd5aUtFRDh3N3dvd0xfQmNSQmRMNFcxV2ZyWlZFUEFxNUdIOHFMWktOMFgyLTJmVC1pUWxwQUVjVEJVS2xiNnhTRWJCSEZUNzFBbzdCNHNVWTZhMFJqNzYwa0gxVTRBRUlQVmVuZUxFajNKcw?oc=5"" target=""_blank"">Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili™. Enters U.S. Ophthalmology Market</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMi-wFBVV95cUxOeGRuOEpEaURCa1IyQjZsSzkydERHN2VJYmdHSm1pZFRhMFN4SzdJcDZCVERQbHZJQVczVVJjQUFQNXNyZWpLLTBiVjhuMUhwWWZkVHVPNjlUUUh0X3RHQTAxdHE0WHdhdGVJWDZ5U0ZVMzZydjMxRmtWUng3OWFQSFpIUmw4ME1MYjNiNHEtOEd5aUtFRDh3N3dvd0xfQmNSQmRMNFcxV2ZyWlZFUEFxNUdIOHFMWktOMFgyLTJmVC1pUWxwQUVjVEJVS2xiNnhTRWJCSEZUNzFBbzdCNHNVWTZhMFJqNzYwa0gxVTRBRUlQVmVuZUxFajNKcw?oc=5,Google News,Biocon biosimilarity study,"Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili™. Enters U.S. Ophthalmology Market - PR Newswire <a href=""https://news.google.com/rss/articles/CBMi-wFBVV95cUxOeGRuOEpEaURCa1IyQjZsSzkydERHN2VJYmdHSm1pZFRhMFN4SzdJcDZCVERQbHZJQVczVVJjQUFQNXNyZWpLLTBiVjhuMUhwWWZkVHVPNjlUUUh0X3RHQTAxdHE0WHdhdGVJWDZ5U0ZVMzZydjMxRmtWUng3OWFQSFpIUmw4ME1MYjNiNHEtOEd5aUtFRDh3N3dvd0xfQmNSQmRMNFcxV2ZyWlZFUEFxNUdIOHFMWktOMFgyLTJmVC1pUWxwQUVjVEJVS2xiNnhTRWJCSEZUNzFBbzdCNHNVWTZhMFJqNzYwa0gxVTRBRUlQVmVuZUxFajNKcw?oc=5"" target=""_blank"">Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili™. Enters U.S. Ophthalmology Market</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",0.6510518789291382,positive,0.6510518789291382,0.0,neutral,0.0,0.7351,0.154,0.0,0.846,0.0,0.0,0.37202964510236464,0.6930759394645691,approval_process,0.5,['FDA approval'],False,True,16,0.0
2025-04-24,2025-04-24 07:00:00,Biosimilars Market Expansion in 2025: The Next Big Thing - openPR.com,"<a href=""https://news.google.com/rss/articles/CBMilgFBVV95cUxNenlqNGQ3MVdoS0RCT1hoMGpUNVhNcUdBOHpKbldTd2I3NlpMTHJDWnMySzVZTTliSHdNRklHcjA0RldrOC1qWHZ3UU5kNEJyOTFXOFJJazVJb2VvY3hxUUk5d0x4blprMk9OQVlXVV9WQU9PLVBqUkF5M2Y4UWdtMkltMHdyRjBHV0FJZzN2cjRKdmVPSUE?oc=5"" target=""_blank"">Biosimilars Market Expansion in 2025: The Next Big Thing</a>&nbsp;&nbsp;<font color=""#6f6f6f"">openPR.com</font>",https://news.google.com/rss/articles/CBMilgFBVV95cUxNenlqNGQ3MVdoS0RCT1hoMGpUNVhNcUdBOHpKbldTd2I3NlpMTHJDWnMySzVZTTliSHdNRklHcjA0RldrOC1qWHZ3UU5kNEJyOTFXOFJJazVJb2VvY3hxUUk5d0x4blprMk9OQVlXVV9WQU9PLVBqUkF5M2Y4UWdtMkltMHdyRjBHV0FJZzN2cjRKdmVPSUE?oc=5,Google News,Biocon market expansion,"Biosimilars Market Expansion in 2025: The Next Big Thing - openPR.com <a href=""https://news.google.com/rss/articles/CBMilgFBVV95cUxNenlqNGQ3MVdoS0RCT1hoMGpUNVhNcUdBOHpKbldTd2I3NlpMTHJDWnMySzVZTTliSHdNRklHcjA0RldrOC1qWHZ3UU5kNEJyOTFXOFJJazVJb2VvY3hxUUk5d0x4blprMk9OQVlXVV9WQU9PLVBqUkF5M2Y4UWdtMkltMHdyRjBHV0FJZzN2cjRKdmVPSUE?oc=5"" target=""_blank"">Biosimilars Market Expansion in 2025: The Next Big Thing</a>&nbsp;&nbsp;<font color=""#6f6f6f"">openPR.com</font>",0.0,neutral,0.8369675874710083,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.04,0.0,0.8369675874710083,post_approval,0.3,['market expansion'],False,False,7,0.0
2025-02-11,2025-02-11 08:00:00,Biocon betting big on new product launches for growth - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon betting big on new product launches for growth</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News,Biocon market expansion,"Biocon betting big on new product launches for growth - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon betting big on new product launches for growth</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.0,neutral,0.7709921598434448,0.0,neutral,0.0,0.3818,0.094,0.0,0.906,0.09610389610389611,0.21558441558441557,0.0,0.41629868531578024,post_approval,0.3,['product launch'],False,True,12,0.0
2024-12-02,2024-12-02 08:00:00,Biocon's Shares Price Jumps 4% after FDA Approval of Yesintek; Technical Charts & Resistance Levels - topnews.in,"<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxPM1p0dkQwbWFUZzN3YkVzclVDOUFRQ3hCM0NYUEU2S3QzZl9PVHk3RFR6WUlfWkY4dHZrTjhDRWh0WEZTS25Cck16aHVCSWRNZVRIcEV1SmdnR3NZQ1FRa3I5REhhc05WOVVyTTNlV05JaWdobUQ3M0Y4bTk2RjN3YjgwcnpDY0l2MTNiZlFzTjVpOTBRaGtuRnVmZU56Y1dDbE1za0owVmJlay0zRTFhdzIxWlpJR1NvRUE?oc=5"" target=""_blank"">Biocon's Shares Price Jumps 4% after FDA Approval of Yesintek; Technical Charts & Resistance Levels</a>&nbsp;&nbsp;<font color=""#6f6f6f"">topnews.in</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxPM1p0dkQwbWFUZzN3YkVzclVDOUFRQ3hCM0NYUEU2S3QzZl9PVHk3RFR6WUlfWkY4dHZrTjhDRWh0WEZTS25Cck16aHVCSWRNZVRIcEV1SmdnR3NZQ1FRa3I5REhhc05WOVVyTTNlV05JaWdobUQ3M0Y4bTk2RjN3YjgwcnpDY0l2MTNiZlFzTjVpOTBRaGtuRnVmZU56Y1dDbE1za0owVmJlay0zRTFhdzIxWlpJR1NvRUE?oc=5,Google News,Biocon market expansion,"Biocon's Shares Price Jumps 4% after FDA Approval of Yesintek; Technical Charts & Resistance Levels - topnews.in <a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxPM1p0dkQwbWFUZzN3YkVzclVDOUFRQ3hCM0NYUEU2S3QzZl9PVHk3RFR6WUlfWkY4dHZrTjhDRWh0WEZTS25Cck16aHVCSWRNZVRIcEV1SmdnR3NZQ1FRa3I5REhhc05WOVVyTTNlV05JaWdobUQ3M0Y4bTk2RjN3YjgwcnpDY0l2MTNiZlFzTjVpOTBRaGtuRnVmZU56Y1dDbE1za0owVmJlay0zRTFhdzIxWlpJR1NvRUE?oc=5"" target=""_blank"">Biocon's Shares Price Jumps 4% after FDA Approval of Yesintek; Technical Charts & Resistance Levels</a>&nbsp;&nbsp;<font color=""#6f6f6f"">topnews.in</font>",0.9212486147880554,positive,0.9212486147880554,0.0,neutral,0.0,0.8625,0.275,0.0,0.725,0.0,0.06666666666666667,0.5264277798788888,0.8918743073940277,approval_process,0.5,['FDA approval'],False,True,16,0.0
2024-08-30,2024-08-30 07:00:00,Akums Drugs strengthens global presence with European market expansion - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Akums Drugs strengthens global presence with European market expansion</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon market expansion,"Akums Drugs strengthens global presence with European market expansion - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Akums Drugs strengthens global presence with European market expansion</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.9094298481941223,positive,0.9094298481941223,0.0,neutral,0.0,0.7184,0.214,0.0,0.786,0.0,0.0,0.5196741989680699,0.8139149240970611,post_approval,0.3,['market expansion'],False,False,7,0.0
2025-06-27,2025-06-27 07:00:23,Rethinking the Future: Nasopharyngeal Cancer Market Expansion - openPR.com,"<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxPTFRzcF9zdTBlaFl3TG52aEI0Z2JzTDJROEFHLWxWTHZwYk14YUJSbFpYblZDMmlQbE1aN1hnR25wY1hWRnpGU0pkZUxLUmlpdVpBNFJ5TVVSOHdoZUc4cy1jd2lIZFdPc3FWZkUyakVoM0RkUjNEaGtTTmlBZGRiNmRmeHFyY09sd1R0VkN4NUNRbHlfZzVBY1JVM04?oc=5"" target=""_blank"">Rethinking the Future: Nasopharyngeal Cancer Market Expansion</a>&nbsp;&nbsp;<font color=""#6f6f6f"">openPR.com</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxPTFRzcF9zdTBlaFl3TG52aEI0Z2JzTDJROEFHLWxWTHZwYk14YUJSbFpYblZDMmlQbE1aN1hnR25wY1hWRnpGU0pkZUxLUmlpdVpBNFJ5TVVSOHdoZUc4cy1jd2lIZFdPc3FWZkUyakVoM0RkUjNEaGtTTmlBZGRiNmRmeHFyY09sd1R0VkN4NUNRbHlfZzVBY1JVM04?oc=5,Google News,Biocon market expansion,"Rethinking the Future: Nasopharyngeal Cancer Market Expansion - openPR.com <a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxPTFRzcF9zdTBlaFl3TG52aEI0Z2JzTDJROEFHLWxWTHZwYk14YUJSbFpYblZDMmlQbE1aN1hnR25wY1hWRnpGU0pkZUxLUmlpdVpBNFJ5TVVSOHdoZUc4cy1jd2lIZFdPc3FWZkUyakVoM0RkUjNEaGtTTmlBZGRiNmRmeHFyY09sd1R0VkN4NUNRbHlfZzVBY1JVM04?oc=5"" target=""_blank"">Rethinking the Future: Nasopharyngeal Cancer Market Expansion</a>&nbsp;&nbsp;<font color=""#6f6f6f"">openPR.com</font>",0.0,neutral,0.8748514652252197,0.0,neutral,0.0,-0.8689,0.0,0.355,0.645,0.0,0.08333333333333333,0.0,0.8718757326126099,post_approval,0.3,['market expansion'],False,False,7,0.0
2025-01-30,2025-01-30 08:00:00,"FDA Reviews Golimumab Biosimilar, Samsung Biologics Hits Record Sales, Japan Approves Stelara Biosimilar - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMi3AFBVV95cUxQQ29SS0ZTRHJBU2doTXNOVzJ6X0xrYVJYbWhQQkxmNVVFd2U5ZjZJenR0ZGpoN201OERpb3o2cWFMWnJxRzBwblZLaHpXVlRuWEIyeXUxeExQOGN1MTZUaXpwdEw5N2NEeXJzV0hXQ1ZreUJyZkpXVlVia1hfU1BaMFZvbU5fVWhGVkROVjNHUmdRTk1Lc0txRFFwUy1kNUlUcEtxQm1Qcmk0ZGhwVzdvcm1IMkpUVU1Ha2IwWVlTUjRHbTVXVEN2VjdjVDdfb3VpT2tBTzA5WlA1M2Rx?oc=5"" target=""_blank"">FDA Reviews Golimumab Biosimilar, Samsung Biologics Hits Record Sales, Japan Approves Stelara Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMi3AFBVV95cUxQQ29SS0ZTRHJBU2doTXNOVzJ6X0xrYVJYbWhQQkxmNVVFd2U5ZjZJenR0ZGpoN201OERpb3o2cWFMWnJxRzBwblZLaHpXVlRuWEIyeXUxeExQOGN1MTZUaXpwdEw5N2NEeXJzV0hXQ1ZreUJyZkpXVlVia1hfU1BaMFZvbU5fVWhGVkROVjNHUmdRTk1Lc0txRFFwUy1kNUlUcEtxQm1Qcmk0ZGhwVzdvcm1IMkpUVU1Ha2IwWVlTUjRHbTVXVEN2VjdjVDdfb3VpT2tBTzA5WlA1M2Rx?oc=5,Google News,Biocon annual results,"FDA Reviews Golimumab Biosimilar, Samsung Biologics Hits Record Sales, Japan Approves Stelara Biosimilar - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMi3AFBVV95cUxQQ29SS0ZTRHJBU2doTXNOVzJ6X0xrYVJYbWhQQkxmNVVFd2U5ZjZJenR0ZGpoN201OERpb3o2cWFMWnJxRzBwblZLaHpXVlRuWEIyeXUxeExQOGN1MTZUaXpwdEw5N2NEeXJzV0hXQ1ZreUJyZkpXVlVia1hfU1BaMFZvbU5fVWhGVkROVjNHUmdRTk1Lc0txRFFwUy1kNUlUcEtxQm1Qcmk0ZGhwVzdvcm1IMkpUVU1Ha2IwWVlTUjRHbTVXVEN2VjdjVDdfb3VpT2tBTzA5WlA1M2Rx?oc=5"" target=""_blank"">FDA Reviews Golimumab Biosimilar, Samsung Biologics Hits Record Sales, Japan Approves Stelara Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.6945764422416687,positive,0.6945764422416687,0.0,neutral,0.0,0.6597,0.144,0.0,0.856,-0.05,0.05,0.3969008241380964,0.46809214741388955,regulatory_review,0.45,['FDA review'],False,False,10,0.0
2025-04-11,2025-04-11 07:00:00,Biocon share price rises 4% on US FDA approval for cancer drug - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share price rises 4% on US FDA approval for cancer drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon share price rises 4% on US FDA approval for cancer drug - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share price rises 4% on US FDA approval for cancer drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.8850592970848083,positive,0.8850592970848083,0.0,neutral,0.0,-0.0516,0.256,0.213,0.531,0.0,0.0,0.5057481697627476,0.46832964854240416,approval_process,0.5,['FDA approval'],False,True,16,0.0
2024-09-02,2024-09-02 07:00:00,Biocon shares gain after arm gets multiple USFDA approval - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares gain after arm gets multiple USFDA approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon shares gain after arm gets multiple USFDA approval - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares gain after arm gets multiple USFDA approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.8280218839645386,positive,0.8280218839645386,0.0,neutral,0.0,0.9231,0.457,0.0,0.543,0.0,0.0,0.47315536226545063,0.8755609419822693,approval_process,0.5,['FDA approval'],False,True,16,0.0
